Benzinga | Dec 17, 2021 07:43AM EST

Goldman Sachs Initiates Coverage On Johnson & Johnson with Neutral Rating, Announces Price Target of $161

Goldman Sachs analyst Chris Shibutani initiates coverage on Johnson & Johnson (NYSE:JNJ) with a Neutral rating and announces Price Target of $161.